Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
about
Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/CCDH1Regulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factorsAshwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activityTanshinones inhibit the growth of breast cancer cells through epigenetic modification of Aurora A expression and functionPhosphorylation and activation of androgen receptor by Aurora-ABioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in miceSerine/threonine kinase 15 gene polymorphism and risk of digestive system cancers: A meta-analysis.Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC).A non-mitotic role for Aurora kinase A as a direct activator of cell migration upon interaction with PLD, FAK and Src.Androgen receptor signaling in prostate cancer development and progression.Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis.A functional cooperativity between Aurora A kinase and LIM kinase1: implication in the mitotic processAurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.Targeting Aurora kinases in ovarian cancer.Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice.AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer.A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia.Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostateAurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization.Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells.Primary cilia are lost in preinvasive and invasive prostate cancer.The expression of AURKA is androgen regulated in castration-resistant prostate cancer.Expression profiles of NPHP1 in the germ cells in the semen of men with male factor infertility.RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680).Antizyme1 mediates AURKAIP1-dependent degradation of Aurora-A.Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.
P2860
Q24292955-F6AE87EC-F51D-4784-A67E-208B650D9BBEQ26771541-F01BE250-1303-4E51-8620-C506A2F5A092Q28480426-C4F3BBC1-040A-4D7E-B9D7-4A9F3CB5F338Q34224775-5CA85E7F-1CA9-419F-B13B-A0E2C259416CQ34236635-B9FDD704-F0F1-48B6-B468-0F36ADA36322Q34544275-0DAF81ED-E290-494B-8F41-0770943FDDD7Q34585384-B11C474E-B794-45BC-A2CC-4A39B48A5C59Q34778993-15702F76-910A-43A0-87C3-C8A09EEB81FBQ35029166-EF593CC2-3CED-447E-AA30-6D4A9746B50AQ35183663-610CF07A-BF83-40F2-B22D-E5C618CB2F2EQ35782259-CE4B0735-4990-4F09-A945-2BE7111F41F1Q35801399-A776FAB8-B339-460B-81B1-7F8481878A9FQ35859974-16FC52A8-8A18-4F9B-B10D-4C17A3810175Q36379376-620FEEF3-B602-4F8F-83E6-F084033923C0Q37309570-3E2F46EA-C6D4-445E-906E-0B40FD115988Q37362863-79A44FF8-AB82-42E4-9F75-824BE23CCF21Q37536006-53E49DEB-06E9-4498-8BAC-C56F7302C4CBQ37613047-2CF5187B-1A6A-43F4-9004-1F4553AAA3A8Q38515431-CE556147-BC08-4A16-B742-93676D9CDFB2Q38894287-C8575160-F0D4-4D03-A9C2-28DB5AF046B4Q39253801-C3C7BC9B-0128-41E8-9398-9613817FFBBAQ40009243-A17319A0-B7CF-4BD3-9004-579633482156Q41298456-37BEB81B-5735-4EC8-8116-B242E766B24CQ47096576-ABF0B6DC-4E40-40E7-ABD1-6AC676F53574Q47919079-A2BBB801-3CF1-458F-8F47-D2B82D70E12AQ49025576-0791AACD-F75E-4A4E-8F2C-85CF1AF5BB15Q51798018-AE4D7DA8-2CE8-4FE6-8845-EFD47F75372BQ53552089-24CCB961-07CF-45EB-A6A4-A5897158863C
P2860
Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
@en
type
label
Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
@en
prefLabel
Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
@en
P2093
P356
P1433
P1476
Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
@en
P2093
Holly McKlveen Buschhorn
Margaret C Hardy
Raymond B Nagle
Robert R Klein
Susan M Chambers
Sylvan Green
P2860
P304
P356
10.1002/PROS.20247
P577
2005-09-01T00:00:00Z